Dr Kristof Raemdonck

Kristof graduated from the KAHO Sint-Lieven (Ghent, Belgium) in 2002 in Laboratory and Food Technology, Pharmaceutical and Biological Techniques. Upon graduation he joined the Preclinical Pharmacokinetics and Drug Evaluation group at Janssen Pharmaceutica, a division of Johnson & Johnson PRD, as a Research Assistant. Here he was primarily responsible for planning and performing in-vivo pharmacokinetic, toxicokinetic and absorption-distribution studies and acquired the necessary in-vivo skills that now allow him to develop and further understand disease animal models.

After moving to London in 2004, Kristof Raemdonck joined the Respiratory Pharmacology Group at Imperial College of Science Technology and Medicine in January 2005 as a Research Technician and has since, within the same group started a part-time PhD.

His work in the respiratory pharmacology group is aimed at the improvement and investigation of in vivo models of asthma and Chronic Obstructive Pulmonary Disease and focuses mainly on disease induced cellular burden within the airways and functional lung changes. As such he has gained expertise in various non-invasive and invasive lung function techniques including Whole Body Plethysmography, Forced Manoeuvres and classical Resistance and Compliance. Within the group Kristof is now a part-time postgraduate student investigating the use of different allergens in asthma modelling and the driving mechanism behind the allergen induced late asthmatic response in a pre-clinical rat model of allergic asthma.